Condition category
Cancer
Date applied
28/12/2006
Date assigned
28/12/2006
Last edited
20/02/2007
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr F A G Hout

ORCID ID

Contact details

VU Medical Center
Department of Public and Occupational Health/EMGO Institute
Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands
+31 (0)20 444 9682
e.hout@vumc.nl

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

Study hypothesis

The intervention will lead to:
1. More knowledge about (the use of) prescibed medicines
2. A better use of medicines during the stay in the hospital and after discharge

Ethics approval

Approval received from the Medical Ethics Review Committee, VU University Medical Centre Amsterdam on the 25th January 2007.

Study design

Non-randomised, controlled, parallel group trial

Primary study design

Interventional

Secondary study design

Non randomised controlled trial

Trial setting

Not specified

Trial type

Quality of life

Patient information sheet

Condition

Cancer, Lung disease

Intervention

1. Personalised computer generated medication reminder charts during admission and discharge and brochures about specific medicines
2. Patient safety chart with instructions for safe and correct use of medicines

The intervention measurements at the departments of lung diseases and oncology lasts three months. The control measurements last three months (same departments).

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

1. Difference in knowledge about prescribed medicines between intervention and control group at measurement II, per patient corrected for the basis at measurement I (method: questionnaires)
2. Differences in correct use of medicines between intervention and control group at measurement III (method: questionnaires)

Secondary outcome measures

1. Differences in spotting and reporting medication deviations during the distribution of medicines in hospital between intervention and control group (measurement II)
2. Differences in satisfaction about the received information about medicines (measurement II)

Overall trial start date

02/10/2006

Overall trial end date

01/06/2007

Reason abandoned

Eligibility

Participant inclusion criteria

1. Admission at one of the participating departments
2. Informed consent
3. Duration of admission at least three days maximally a month

Participant type

Patient

Age group

Adult

Gender

Not Specified

Target number of participants

240

Participant exclusion criteria

1. Patients younger than 18 years
2. Patients who are emotionally or physically not capable to participate
3. Senile dementia, confusion of the patient
4. Inability to express in Dutch language

Recruitment start date

02/10/2006

Recruitment end date

01/06/2007

Locations

Countries of recruitment

Netherlands

Trial participating centre

VU Medical Center
Amsterdam
1081 BT
Netherlands

Sponsor information

Organisation

VU University Medical Center (The Netherlands)

Sponsor details

Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands

Sponsor type

Hospital/treatment centre

Website

http://www.vumc.nl/

Funders

Funder type

Industry

Funder name

Agis Health Insurance Company (Agis-zorgverzekering) (The Netherlands)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

Dutch Association of Medical Specialists (Orde van Medisch Specialisten) (The Netherlands)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes